Artificial intelligence in preventive cardiology.

Journal: Progress in cardiovascular diseases
PMID: 38460897

Abstract

Artificial intelligence (AI) is a field of study that strives to replicate aspects of human intelligence into machines. Preventive cardiology, a subspeciality of cardiovascular (CV) medicine, aims to target and mitigate known risk factors for CV disease (CVD). AI's integration into preventive cardiology may introduce novel treatment interventions and AI-centered clinician assistive tools to reduce the risk of CVD. AI's role in nutrition, weight loss, physical activity, sleep hygiene, blood pressure, dyslipidemia, smoking, alcohol, recreational drugs, and mental health has been investigated. AI has immense potential to be used for the screening, detection, and monitoring of the mentioned risk factors. However, the current literature must be supplemented with future clinical trials to evaluate the capabilities of AI interventions for preventive cardiology. This review discusses present examples, potentials, and limitations of AI's role for the primary and secondary prevention of CVD.

Authors

  • Adham El Sherbini
    Faculty of Health Sciences, Queen's University, Kingston, ON, Canada.
  • Robert S Rosenson
    Cardiometabolics Unit, Mount Sinai Hospital, Mount Sinai Heart, NY, United States of America.
  • Mahmoud Al Rifai
    Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, United States of America.
  • Hafeez Ul Hassan Virk
    Department of Cardiovascular Diseases, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Zhen Wang
    Department of Otolaryngology, Longgang Otolaryngology hospital & Shenzhen Key Laboratory of Otolaryngology, Shenzhen Institute of Otolaryngology, Shenzhen, Guangdong, China.
  • Salim Virani
    Section of Cardiology, The Aga Khan University, Texas Heart Institute, Baylor College of Medicine, Houston, TX, United States of America.
  • Benjamin S Glicksberg
    The Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, 770 Lexington Ave, 15th Fl, New York, NY, 10065, USA.
  • Carl J Lavie
    John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, USA.
  • Chayakrit Krittanawong
    HumanX, Delaware, DE, USA.

Keywords

External Resources

Popular Topics
Recent Journals